Endogenous Interleukin-12 is Critical for Controlling the Late but Not the Early Stage of Leishmania Mexicana Infection in C57BL/6 Mice

Overview

Journal Infect Immun

Publisher American Society for Microbiology

Specialty Allergy & Immunology

Date 2002 Aug 17

PMID 12183555

Citations 9

Authors

Fabiola Aguilar Torrentera

Jon D Laman

Marjan van Meurs

Luciano Adorini

Eric Muraille

Y Carlier

Affiliations

Soon will be listed here.

Abstract

The role of interleukin-12 (IL-12) has been clearly established in the resistance of C57BL/6 (B6) mice to Leishmania major infection, but its involvement in the control of Leishmania mexicana infection remains to be determined. Here, we show the following. (i) L. mexicana, in contrast to L. major, induces the development of nonhealing lesions in B6 mice. (ii) Cells expressing IL-12p40, gamma interferon (IFN-gamma), NOS2, and CD40L are numerous in the footpad lesion and/or the draining popliteal lymph node of animals infected for up to 14 weeks with L. mexicana. (iii) B6 mice, either IL-12p40 deficient or treated with IL-12p40-neutralizing antibodies, display a dramatic enhancement of primary and secondary lesions leading to death 10 weeks after inoculation with L. mexicana. (iv) Splenocytes harvested 4 and 8 weeks after infection of IL-12p40(-/-) B6 mice with L. mexicana are unable to produce IFN-gamma, but secrete IL-4, IL-10, and IL-18. Thus, the early control of L. mexicana infection by B6 mice is independent of IL-12, whereas IL-12 and Th1 responses play a key role in controlling the late stages of L. mexicana infection. However, they fail to resolve lesions, in contrast to L. major infection, emphasizing the different outcomes induced by these two Leishmania species in B6 mice.

Citing Articles

Recurrent Visceral Leishmaniasis in a Case With Interleukin-12 Receptor Beta-1 Deficiency.

Uygun H, Oren A, Sahinoglu E, Akbayram S Acta Parasitol. 2024; 69(4):2069-2072.

PMID: 39388053 DOI: 10.1007/s11686-024-00926-8.

Animal models for the study of leishmaniasis immunology.

Loria-Cervera E, Andrade-Narvaez F Rev Inst Med Trop Sao Paulo. 2014; 56(1):1-11.

PMID: 24553602 PMC: 4085833. DOI: 10.1590/S0036-46652014000100001.

Nitric oxide production by Peromyscus yucatanicus (Rodentia) infected with Leishmania (Leishmania) mexicana.

Loria-Cervera E, Sosa-Bibiano E, Villanueva-Lizama L, Van Wynsberghe N, Canto-Lara S, Batun-Cutz J Mem Inst Oswaldo Cruz. 2013; 108(2):172-7.

PMID: 23579796 PMC: 3970676. DOI: 10.1590/0074-0276108022013008.

T helper1/t helper2 cells and resistance/susceptibility to leishmania infection: is this paradigm still relevant?.

Alexander J, Brombacher F Front Immunol. 2012; 3:80.

PMID: 22566961 PMC: 3342373. DOI: 10.3389/fimmu.2012.00080.

Pathogen-derived oligosaccharides improve innate immune response to intracellular parasite infection.

Osanya A, Song E, Metz K, Shimak R, Boggiatto P, Huffman E Am J Pathol. 2011; 179(3):1329-37.

PMID: 21763266 PMC: 3157181. DOI: 10.1016/j.ajpath.2011.05.053.

References

Rodriguez-Sosa M, Monteforte G, Satoskar A . Susceptibility to Leishmania mexicana infection is due to the inability to produce IL-12 rather than lack of IL-12 responsiveness. Immunol Cell Biol. 2001; 79(4):320-2. DOI: 10.1046/j.1440-1711.2001.01014.x. View

Yoshida H, Hamano S, Senaldi G, Covey T, Faggioni R, Mu S . WSX-1 is required for the initiation of Th1 responses and resistance to L. major infection. Immunity. 2001; 15(4):569-78. DOI: 10.1016/s1074-7613(01)00206-0. View

Ma X, Trinchieri G . Regulation of interleukin-12 production in antigen-presenting cells. Adv Immunol. 2001; 79:55-92. DOI: 10.1016/s0065-2776(01)79002-5. View

Padigel U, Perrin P, Farrell J . The development of a Th1-type response and resistance to Leishmania major infection in the absence of CD40-CD40L costimulation. J Immunol. 2001; 167(10):5874-9. DOI: 10.4049/jimmunol.167.10.5874. View

Talamas-Rohana P . In vitro indomethacin administration upregulates interleukin-12 production and polarizes the immune response towards a Th1 type in susceptible BALB/c mice infected with Leishmania mexicana. Parasite Immunol. 2001; 23(11):599-606. DOI: 10.1046/j.1365-3024.2001.00421.x. View

Nakahira M, Ahn H, Park W, Gao P, Tomura M, Park C . Synergy of IL-12 and IL-18 for IFN-gamma gene expression: IL-12-induced STAT4 contributes to IFN-gamma promoter activation by up-regulating the binding activity of IL-18-induced activator protein 1. J Immunol. 2002; 168(3):1146-53. DOI: 10.4049/jimmunol.168.3.1146. View

Torrentera F, Lambot M, Laman J, van Meurs M, Kiss R, Noel J . Parasitic load and histopathology of cutaneous lesions, lymph node, spleen, and liver from BALB/c and C57BL/6 mice infected with Leishmania mexicana. Am J Trop Med Hyg. 2002; 66(3):273-9. DOI: 10.4269/ajtmh.2002.66.273. View

Velasco O, Savarino S, WALTON B, Gam A, NEVA F . Diffuse cutaneous leishmaniasis in Mexico. Am J Trop Med Hyg. 1989; 41(3):280-8. View

Galbiati F, Rogge L, Adorini L . IL-12 receptor regulation in IL-12-deficient BALB/c and C57BL/6 mice. Eur J Immunol. 1999; 30(1):29-37. DOI: 10.1002/1521-4141(200001)30:1<29::AID-IMMU29>3.0.CO;2-7. View

10.

Ohkusu K, Yoshimoto T, Takeda K, Ogura T, Kashiwamura S, Iwakura Y . Potentiality of interleukin-18 as a useful reagent for treatment and prevention of Leishmania major infection. Infect Immun. 2000; 68(5):2449-56. PMC: 97445. DOI: 10.1128/IAI.68.5.2449-2456.2000. View

11.

Monteforte G, Takeda K, Rodriguez-Sosa M, Akira S, David J, Satoskar A . Genetically resistant mice lacking IL-18 gene develop Th1 response and control cutaneous Leishmania major infection. J Immunol. 2000; 164(11):5890-3. DOI: 10.4049/jimmunol.164.11.5890. View

12.

Jones D, Buxbaum L, Scott P . IL-4-independent inhibition of IL-12 responsiveness during Leishmania amazonensis infection. J Immunol. 2000; 165(1):364-72. DOI: 10.4049/jimmunol.165.1.364. View

13.

Park A, Hondowicz B, Scott P . IL-12 is required to maintain a Th1 response during Leishmania major infection. J Immunol. 2000; 165(2):896-902. DOI: 10.4049/jimmunol.165.2.896. View

14.

Hondowicz B, Park A, Elloso M, Scott P . Maintenance of IL-12-responsive CD4+ T cells during a Th2 response in Leishmania major-infected mice. Eur J Immunol. 2000; 30(7):2007-14. DOI: 10.1002/1521-4141(200007)30:7<2007::AID-IMMU2007>3.0.CO;2-W. View

15.

Torrentera F, Glaichenhaus N, Laman J, Carlier Y . T-cell responses to immunodominant LACK antigen do not play a critical role in determining susceptibility of BALB/c mice to Leishmania mexicana. Infect Immun. 2000; 69(1):617-21. PMC: 97931. DOI: 10.1128/IAI.69.1.617-621.2001. View

16.

Desbarats J, Stone J, Lin L, Zakeri Z, Davis G, Pfeiffer L . Rapid early onset lymphocyte cell death in mice resistant, but not susceptible to Leishmania major infection. Apoptosis. 2001; 5(2):189-96. DOI: 10.1023/a:1009601200580. View

17.

Bennett C, Misslitz A, Colledge L, Aebischer T, Blackburn C . Silent infection of bone marrow-derived dendritic cells by Leishmania mexicana amastigotes. Eur J Immunol. 2001; 31(3):876-83. DOI: 10.1002/1521-4141(200103)31:3<876::aid-immu876>3.0.co;2-i. View

18.

Nishikomori R, Gurunathan S, Nishikomori K, Strober W . BALB/c mice bearing a transgenic IL-12 receptor beta 2 gene exhibit a nonhealing phenotype to Leishmania major infection despite intact IL-12 signaling. J Immunol. 2001; 166(11):6776-83. DOI: 10.4049/jimmunol.166.11.6776. View

19.

Overath P, Harbecke D . Course of Leishmania infection in beta 2-microglobulin-deficient mice. Immunol Lett. 1993; 37(1):13-7. DOI: 10.1016/0165-2478(93)90126-m. View

20.

Convit J, Ulrich M, Fernandez C, Tapia F, Castes M, Rondon A . The clinical and immunological spectrum of American cutaneous leishmaniasis. Trans R Soc Trop Med Hyg. 1993; 87(4):444-8. DOI: 10.1016/0035-9203(93)90030-t. View